Sort

Search

01/06/2022 Outbreaks of Gastroenteritis Due to Norovirus in Schools and Summer Camps in Catalonia, 2017-2019
Parron, I, Barrabeig, I, Soldevila, N, Bartolome, R, Guix, S, Rius, C, Cornejo-Sanchez, T, Izquierdo, C, Dominguez, A. Outbreaks of Gastroenteritis Due to Norovirus in Schools and Summer Camps in Catalonia, 2017-2019. Microbiology Spectrum. 2022; 10(3)DOI:10.1128/spectrum.00119-22. PMID:35543555. IF:3.700(Q2/5D).
01/06/2022 Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study
Tunesi, S, Le Du, D, Gualano, G, Millet, JP, Skrahin, A, Bothamley, G, Casas, X, Goletti, D, Lange, C, Musso, M, Palmieri, F, Pourcher, V, Rioux, C, Skrahina, A, Veziris, N, Viatushka, D, Jachym-Frechet, M, Guglielmetti, L, Marigot-Outtandy, D, Lescure, X, Dubert, M, Yazdanpanah, Y, Caumes, E, Choinier, P, Haddad, E, Kowalczyk, J, Laurichesse, H, Lesens, O, Aubry, A, Bonnet, I, Morel, F. Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study. JOURNAL OF INFECTION. 2022; 84(6)DOI:10.1016/j.jinf.2022.03.004. PMID:35271917. IF:28.200(Q1/1D).
01/06/2022 Effectiveness of an Energy-Counseling Intervention in Reducing Energy Poverty: Evidence from a Quasi-Experimental Study in a Southern European City
Carrere, J, Belvis, F, Peralta, A, Mari-Dell'Olmo, M, Lopez, MJ, Benach, J, Novoa, AM. Effectiveness of an Energy-Counseling Intervention in Reducing Energy Poverty: Evidence from a Quasi-Experimental Study in a Southern European City. JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE. 2022; 99(3)DOI:10.1007/s11524-022-00642-6. PMID:35622196. IF:6.600(Q1/2D).
01/06/2022 Confidence in a Vaccine against COVID-19 among Registered Nurses in Barcelona, Spain across Two Time Periods
Palma, D, Hernandez, A, Picchio, CA, Jodar, G, Galbany-Estragues, P, Simon, P, Guillaumes, M, Diez, E, Rius, C. Confidence in a Vaccine against COVID-19 among Registered Nurses in Barcelona, Spain across Two Time Periods. Vaccines. 2022; 10(6)DOI:10.3390/vaccines10060873. PMID:35746481. IF:7.800(Q1/2D).